Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leronlimab (PRO 140) in HIV-infected Drug Users
NCT02438345Phase 2Withdrawn
- Sponsor
- Drexel University
- Start
- Nov 2012
- Primary completion
- Feb 2015
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of leronlimab in human immunodeficiency virus infection (HIV), sponsored by Drexel University. Planned start Nov 2012; status: withdrawn.
02
Drugs
leronlimab
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02438345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02438345.